Sigma-1R–Pom121 axis preserves nuclear transport and integrity in poly-PR-induced C9orf72 ALS
Neurobiology of Disease · 2025
DOI: 10.1016/j.nbd.2025.106992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Chun-Yu Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience and Brain Disease Center, China Medical University, Taichung 404328, Taiwan; School of Medicine, College of Medicine, China Medical Univ…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Receptors, sigma, C9orf72 Protein, Active Transport, Cell Nucleus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute on Drug Abuse, U.S. Department of Health and Human Services, National Science and Technology Council.
Abstract (Originalsprache)
Nucleocytoplasmic transport disruption contributes to the pathogenesis of C9orf72-associated amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Among the dipeptide repeat proteins translated from G4C2-repeat RNA, poly-PR is particularly toxic, compromising nuclear envelope integrity and transport. Here, we revealed that poly-PR reduced expression of the nucleoporin Pom121 in NSC-34 cells and in an AAV-mediated poly-PR42 mouse model, resulting in cytoplasmic mislocalization of the neuroprotective transcription factor ATF3 and nuclear envelope damage. Pom121 overexpression restored nuclear ATF3 localization and alleviated poly-PR-induced toxicity. We further identified Sigma-1 receptor (Sigma-1R) as a stabilizer of Pom121 that preserved nuclear integrity and ATF3 function under oxidative stress. Overexpression of Sigma-1R, Pom121, or ATF3 rescued poly-PR-induced cytotoxicity. Our findings defined a protective Sigma-1R/Pom121/ATF3 axis and suggested this pathway as a therapeutic target in C9orf72-linked ALS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroscience and Brain Disease Center, China Medical University, Taichung 404328, Taiwan; School of Medicine, College of Medicine, China Medical University, Taichung 404328, Taiwan.
- Neuroscience and Brain Disease Center, China Medical University, Taichung 404328, Taiwan; Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 404328, Taiwan.
- Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 404328, Taiwan; Ph.D. Program for Aging, China Medical University, Taichung 404328, Taiwan; Translational Medicine Resea…
- Cellular Pathobiology Section, Integrative Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, DHHS, 333 Cassell Drive, Baltimore, MD 21224, USA.
- Neuroscience and Brain Disease Center, China Medical University, Taichung 404328, Taiwan; Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 404328, Taiwan. Electronic add…
Förderung
- National Institute on Drug Abuse
- U.S. Department of Health and Human Services
- National Science and Technology Council
- China Medical University
Zitieren
APA
Lin, C. Y., Wu, H. C., Fu, R. H., Weng, E. F., Hsieh, W. C., Su, T. P., Wu, H. E., & Wang, S. M. (2025). Sigma-1R–Pom121 axis preserves nuclear transport and integrity in poly-PR-induced C9orf72 ALS. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.106992
Vancouver
Lin CY, Wu HC, Fu RH, Weng EF, Hsieh WC, Su TP, et al. Sigma-1R–Pom121 axis preserves nuclear transport and integrity in poly-PR-induced C9orf72 ALS. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2025.106992
BibTeX
@article{Lin2025,
author = {Lin, Chun-Yu and Wu, Hsuan-Cheng and Fu, Ru-Huei and Weng, Eddie Feng-Ju and Hsieh, Wen-Chi and Su, Tsung-Ping and Wu, Hsiang-En and Wang, Shao-Ming},
title = {Sigma-1R–Pom121 axis preserves nuclear transport and integrity in poly-PR-induced C9orf72 ALS},
journal = {Neurobiology of Disease},
year = {2025},
doi = {10.1016/j.nbd.2025.106992}
}
EUVIMED